Dev Labtech Ventures Approves Capital Hike, Share Split, and Bonus Issue

CHEMICALS
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Dev Labtech Ventures Approves Capital Hike, Share Split, and Bonus Issue
Overview

Dev Labtech Venture Limited's board has approved a significant ₹10 crore increase in its authorised share capital to ₹25 crore. The company also greenlit a 1:2 equity share sub-division and a 1:1 bonus share issuance, aiming to enhance market liquidity and shareholder value. A ₹7.44 crore term loan from SIDBI was also sanctioned to fuel growth initiatives.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Key Corporate Actions Approved

Dev Labtech Venture Limited's board has approved a substantial ₹10 crore increase in authorised share capital, raising it from ₹15 crore to ₹25 crore. This move provides the company with greater financial flexibility for future expansion and fundraising.

In parallel, the board greenlit key corporate actions aimed at enhancing shareholder value and market liquidity. These include a sub-division of equity shares: each ₹10 face value share will split into two shares of ₹5 face value.

Furthermore, the company approved a 1:1 bonus share issuance, meaning shareholders will receive one new bonus share for every existing share they hold.

To support its growth objectives, Dev Labtech also secured a term loan of approximately ₹7.44 crore from the Small Industries Development Bank of India (SIDBI).

All these proposals are subject to necessary shareholder approvals, which will be sought through a postal ballot.

Boosting Shareholder Value and Growth

The proposed share split is designed to make the company's stock more accessible and affordable to a wider base of retail investors, potentially boosting trading volumes and liquidity.

The 1:1 bonus issue offers a direct reward to existing shareholders, increasing their stake in the company without additional investment.

The ₹7.44 crore term loan from SIDBI injects crucial capital, likely for expansion, capital expenditure, or working capital needs, signalling the company's growth ambitions.

The increase in authorised share capital provides a financial runway, allowing the company to undertake future fundraising or strategic initiatives more seamlessly.

About Dev Labtech Ventures

Dev Labtech Venture Limited, incorporated in 1993 and formerly known by other names, is a manufacturer and trader of lab-grown and natural diamonds, utilising Chemical Vapor Deposition (CVD) technology. The company has not announced any bonus issues since 2018, making the current 1:1 proposal a notable event for its shareholders.

In March 2023, Dev Labtech had previously raised approximately ₹11.22 crore through a fresh issue of equity shares. More recently, it established a wholly-owned subsidiary, DEV Labtech Venture INC., in Delaware, USA, in FY 2025, indicating international expansion efforts.

Immediate Impact on Shareholders and Capital

The company's authorised share capital is now ₹25 crore, increasing its capacity for future financial strategies.

The share split is expected to lower the per-share price, potentially increasing trading activity and market accessibility.

The 1:1 bonus issue will increase the number of shares held by existing investors at no extra cost.

The term loan from SIDBI injects funds for potential business expansion or operational enhancements.

Crucially, all these significant corporate actions are contingent upon receiving approval from the company's shareholders.

Shareholder Approval is Key Risk

The primary risk for all these proposed actions—the capital hike, share split, and bonus issue—is securing the necessary shareholder approval via postal ballot. Any adverse outcome in the shareholder vote could stall or alter these plans.

Unique Market Position

Dev Labtech Venture operates in the niche manufacturing of lab-grown diamonds, distinct from its listed peers which are predominantly in the broader jewellery retail sector like Titan Company Ltd, Kalyan Jewellers India Ltd, and PC Jeweller Ltd. This focus on manufacturing using technologies like MPCVD positions it uniquely. While direct comparisons of corporate actions are difficult, the underlying aim of enhancing shareholder value is common across the sector.

Looking Ahead: Key Investor Watchpoints

Investors will be tracking the outcome of the postal ballot to gauge shareholder sentiment on the proposed corporate actions.

Key events to watch include the official announcement of the record date for the bonus share issuance and the formal execution and disbursement of the term loan from SIDBI.

The company is also expected to provide updates regarding the precise timelines for the completion of the share split and bonus distribution.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.